中国のスポーツ医学における局所的な疼痛管理治療薬の市場レポートと展望 2021-2027年China Topical Pain Management Therapeutics in Sports Medicine Market Report & Forecast 2021-2027 This report contains market size and forecasts of Topical Pain Management Therapeutics in Sports Medicine in China, including the following market information: China Topical Pain Management Therap... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーThis report contains market size and forecasts of Topical Pain Management Therapeutics in Sports Medicine in China, including the following market information:China Topical Pain Management Therapeutics in Sports Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions) China top five Topical Pain Management Therapeutics in Sports Medicine companies in 2020 (%) The global Topical Pain Management Therapeutics in Sports Medicine market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027. The China Topical Pain Management Therapeutics in Sports Medicine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period. QYResearch has surveyed the Topical Pain Management Therapeutics in Sports Medicine Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: China Topical Pain Management Therapeutics in Sports Medicine Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Topical Pain Management Therapeutics in Sports Medicine Market Segment Percentages, By Type, 2020 (%) Gels Creams Sprays Other China Topical Pain Management Therapeutics in Sports Medicine Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Topical Pain Management Therapeutics in Sports Medicine Market Segment Percentages, By Application, 2020 (%) Hospital Clinic Retail Pharmacy Other Competitor Analysis The report also provides analysis of leading market participants including: Key companies Topical Pain Management Therapeutics in Sports Medicine revenues in China market, 2016-2021 (Estimated), ($ millions) Key companies Topical Pain Management Therapeutics in Sports Medicine revenues share in China market, 2020 (%) Further, the report presents profiles of competitors in the market, key players include: Teva Pharmaceutical Pfizer Hisamitsu Pharmaceutical Mayne Pharma Chattem GlaxoSmithKline Endo Pharmaceuticals Beiersdorf Johnson & Johnson Topical BioMedics 目次1 Introduction to Research & Analysis Reports1.1 Topical Pain Management Therapeutics in Sports Medicine Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Topical Pain Management Therapeutics in Sports Medicine Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Topical Pain Management Therapeutics in Sports Medicine Overall Market Size 2.1 China Topical Pain Management Therapeutics in Sports Medicine Market Size: 2021 VS 2027 2.2 China Topical Pain Management Therapeutics in Sports Medicine Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Topical Pain Management Therapeutics in Sports Medicine Players in China Market 3.2 Top China Topical Pain Management Therapeutics in Sports Medicine Companies Ranked by Revenue 3.3 China Topical Pain Management Therapeutics in Sports Medicine Revenue by Companies 3.4 Top 3 and Top 5 Topical Pain Management Therapeutics in Sports Medicine Companies in China Market, by Revenue in 2020 3.5 Companies Topical Pain Management Therapeutics in Sports Medicine Product Type 3.6 Tier 1, Tier 2 and Tier 3 Topical Pain Management Therapeutics in Sports Medicine Players in China Market 3.6.1 List of Tier 1 Topical Pain Management Therapeutics in Sports Medicine Companies in China 3.6.2 List of Tier 2 and Tier 3 Topical Pain Management Therapeutics in Sports Medicine Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Topical Pain Management Therapeutics in Sports Medicine Market Size Markets, 2021 & 2027 4.1.2 Gels 4.1.3 Creams 4.1.4 Sprays 4.1.5 Other 4.2 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue & Forecasts 4.2.1 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2016-2021 4.2.2 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2022-2027 4.2.3 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Topical Pain Management Therapeutics in Sports Medicine Market Size, 2021 & 2027 5.1.2 Hospital 5.1.3 Clinic 5.1.4 Retail Pharmacy 5.1.5 Other 5.2 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue & Forecasts 5.2.1 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2016-2021 5.2.2 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2022-2027 5.2.3 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue Market Share, 2016-2027 6 Topical Pain Management Therapeutics in Sports Medicine Companies Profiles 6.1 Teva Pharmaceutical 6.1.1 Teva Pharmaceutical Company Details 6.1.2 Teva Pharmaceutical Business Overview 6.1.3 Teva Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Introduction 6.1.4 Teva Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.1.5 Teva Pharmaceutical Recent Developments 6.2 Pfizer 6.2.1 Pfizer Company Details 6.2.2 Pfizer Business Overview 6.2.3 Pfizer Topical Pain Management Therapeutics in Sports Medicine Introduction 6.2.4 Pfizer Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.2.5 Pfizer Recent Developments 6.3 Hisamitsu Pharmaceutical 6.3.1 Hisamitsu Pharmaceutical Company Details 6.3.2 Hisamitsu Pharmaceutical Business Overview 6.3.3 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Introduction 6.3.4 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.3.5 Hisamitsu Pharmaceutical Recent Developments 6.4 Mayne Pharma 6.4.1 Mayne Pharma Company Details 6.4.2 Mayne Pharma Business Overview 6.4.3 Mayne Pharma Topical Pain Management Therapeutics in Sports Medicine Introduction 6.4.4 Mayne Pharma Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.4.5 Mayne Pharma Recent Developments 6.5 Chattem 6.5.1 Chattem Company Details 6.5.2 Chattem Business Overview 6.5.3 Chattem Topical Pain Management Therapeutics in Sports Medicine Introduction 6.5.4 Chattem Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.5.5 Chattem Recent Developments 6.6 GlaxoSmithKline 6.6.1 GlaxoSmithKline Company Details 6.6.2 GlaxoSmithKline Business Overview 6.6.3 GlaxoSmithKline Topical Pain Management Therapeutics in Sports Medicine Introduction 6.6.4 GlaxoSmithKline Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.6.5 GlaxoSmithKline Recent Developments 6.7 Endo Pharmaceuticals 6.7.1 Endo Pharmaceuticals Company Details 6.7.2 Endo Pharmaceuticals Business Overview 6.7.3 Endo Pharmaceuticals Topical Pain Management Therapeutics in Sports Medicine Introduction 6.7.4 Endo Pharmaceuticals Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.7.5 Endo Pharmaceuticals Recent Developments 6.8 Beiersdorf 6.8.1 Beiersdorf Company Details 6.8.2 Beiersdorf Business Overview 6.8.3 Beiersdorf Topical Pain Management Therapeutics in Sports Medicine Introduction 6.8.4 Beiersdorf Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.8.5 Beiersdorf Recent Developments 6.9 Johnson & Johnson 6.9.1 Johnson & Johnson Company Details 6.9.2 Johnson & Johnson Business Overview 6.9.3 Johnson & Johnson Topical Pain Management Therapeutics in Sports Medicine Introduction 6.9.4 Johnson & Johnson Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.9.5 Johnson & Johnson Recent Developments 6.10 Topical BioMedics 6.10.1 Topical BioMedics Company Details 6.10.2 Topical BioMedics Business Overview 6.10.3 Topical BioMedics Topical Pain Management Therapeutics in Sports Medicine Introduction 6.10.4 Topical BioMedics Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.10.5 Topical BioMedics Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer
SummaryThis report contains market size and forecasts of Topical Pain Management Therapeutics in Sports Medicine in China, including the following market information:China Topical Pain Management Therapeutics in Sports Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions) China top five Topical Pain Management Therapeutics in Sports Medicine companies in 2020 (%) The global Topical Pain Management Therapeutics in Sports Medicine market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027. The China Topical Pain Management Therapeutics in Sports Medicine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period. QYResearch has surveyed the Topical Pain Management Therapeutics in Sports Medicine Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: China Topical Pain Management Therapeutics in Sports Medicine Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Topical Pain Management Therapeutics in Sports Medicine Market Segment Percentages, By Type, 2020 (%) Gels Creams Sprays Other China Topical Pain Management Therapeutics in Sports Medicine Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Topical Pain Management Therapeutics in Sports Medicine Market Segment Percentages, By Application, 2020 (%) Hospital Clinic Retail Pharmacy Other Competitor Analysis The report also provides analysis of leading market participants including: Key companies Topical Pain Management Therapeutics in Sports Medicine revenues in China market, 2016-2021 (Estimated), ($ millions) Key companies Topical Pain Management Therapeutics in Sports Medicine revenues share in China market, 2020 (%) Further, the report presents profiles of competitors in the market, key players include: Teva Pharmaceutical Pfizer Hisamitsu Pharmaceutical Mayne Pharma Chattem GlaxoSmithKline Endo Pharmaceuticals Beiersdorf Johnson & Johnson Topical BioMedics Table of Contents1 Introduction to Research & Analysis Reports1.1 Topical Pain Management Therapeutics in Sports Medicine Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Topical Pain Management Therapeutics in Sports Medicine Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Topical Pain Management Therapeutics in Sports Medicine Overall Market Size 2.1 China Topical Pain Management Therapeutics in Sports Medicine Market Size: 2021 VS 2027 2.2 China Topical Pain Management Therapeutics in Sports Medicine Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Topical Pain Management Therapeutics in Sports Medicine Players in China Market 3.2 Top China Topical Pain Management Therapeutics in Sports Medicine Companies Ranked by Revenue 3.3 China Topical Pain Management Therapeutics in Sports Medicine Revenue by Companies 3.4 Top 3 and Top 5 Topical Pain Management Therapeutics in Sports Medicine Companies in China Market, by Revenue in 2020 3.5 Companies Topical Pain Management Therapeutics in Sports Medicine Product Type 3.6 Tier 1, Tier 2 and Tier 3 Topical Pain Management Therapeutics in Sports Medicine Players in China Market 3.6.1 List of Tier 1 Topical Pain Management Therapeutics in Sports Medicine Companies in China 3.6.2 List of Tier 2 and Tier 3 Topical Pain Management Therapeutics in Sports Medicine Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Topical Pain Management Therapeutics in Sports Medicine Market Size Markets, 2021 & 2027 4.1.2 Gels 4.1.3 Creams 4.1.4 Sprays 4.1.5 Other 4.2 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue & Forecasts 4.2.1 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2016-2021 4.2.2 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2022-2027 4.2.3 By Type - China Topical Pain Management Therapeutics in Sports Medicine Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Topical Pain Management Therapeutics in Sports Medicine Market Size, 2021 & 2027 5.1.2 Hospital 5.1.3 Clinic 5.1.4 Retail Pharmacy 5.1.5 Other 5.2 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue & Forecasts 5.2.1 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2016-2021 5.2.2 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue, 2022-2027 5.2.3 By Application - China Topical Pain Management Therapeutics in Sports Medicine Revenue Market Share, 2016-2027 6 Topical Pain Management Therapeutics in Sports Medicine Companies Profiles 6.1 Teva Pharmaceutical 6.1.1 Teva Pharmaceutical Company Details 6.1.2 Teva Pharmaceutical Business Overview 6.1.3 Teva Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Introduction 6.1.4 Teva Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.1.5 Teva Pharmaceutical Recent Developments 6.2 Pfizer 6.2.1 Pfizer Company Details 6.2.2 Pfizer Business Overview 6.2.3 Pfizer Topical Pain Management Therapeutics in Sports Medicine Introduction 6.2.4 Pfizer Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.2.5 Pfizer Recent Developments 6.3 Hisamitsu Pharmaceutical 6.3.1 Hisamitsu Pharmaceutical Company Details 6.3.2 Hisamitsu Pharmaceutical Business Overview 6.3.3 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Introduction 6.3.4 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.3.5 Hisamitsu Pharmaceutical Recent Developments 6.4 Mayne Pharma 6.4.1 Mayne Pharma Company Details 6.4.2 Mayne Pharma Business Overview 6.4.3 Mayne Pharma Topical Pain Management Therapeutics in Sports Medicine Introduction 6.4.4 Mayne Pharma Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.4.5 Mayne Pharma Recent Developments 6.5 Chattem 6.5.1 Chattem Company Details 6.5.2 Chattem Business Overview 6.5.3 Chattem Topical Pain Management Therapeutics in Sports Medicine Introduction 6.5.4 Chattem Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.5.5 Chattem Recent Developments 6.6 GlaxoSmithKline 6.6.1 GlaxoSmithKline Company Details 6.6.2 GlaxoSmithKline Business Overview 6.6.3 GlaxoSmithKline Topical Pain Management Therapeutics in Sports Medicine Introduction 6.6.4 GlaxoSmithKline Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.6.5 GlaxoSmithKline Recent Developments 6.7 Endo Pharmaceuticals 6.7.1 Endo Pharmaceuticals Company Details 6.7.2 Endo Pharmaceuticals Business Overview 6.7.3 Endo Pharmaceuticals Topical Pain Management Therapeutics in Sports Medicine Introduction 6.7.4 Endo Pharmaceuticals Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.7.5 Endo Pharmaceuticals Recent Developments 6.8 Beiersdorf 6.8.1 Beiersdorf Company Details 6.8.2 Beiersdorf Business Overview 6.8.3 Beiersdorf Topical Pain Management Therapeutics in Sports Medicine Introduction 6.8.4 Beiersdorf Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.8.5 Beiersdorf Recent Developments 6.9 Johnson & Johnson 6.9.1 Johnson & Johnson Company Details 6.9.2 Johnson & Johnson Business Overview 6.9.3 Johnson & Johnson Topical Pain Management Therapeutics in Sports Medicine Introduction 6.9.4 Johnson & Johnson Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.9.5 Johnson & Johnson Recent Developments 6.10 Topical BioMedics 6.10.1 Topical BioMedics Company Details 6.10.2 Topical BioMedics Business Overview 6.10.3 Topical BioMedics Topical Pain Management Therapeutics in Sports Medicine Introduction 6.10.4 Topical BioMedics Topical Pain Management Therapeutics in Sports Medicine Revenue in China Market (2016-2021) 6.10.5 Topical BioMedics Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(therapeutics)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |